News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,142 Results
Type
Article (2576)
Company Profile (45)
Press Release (37520)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14192)
Career Advice (78)
Deals (2108)
Drug Delivery (9)
Drug Development (4144)
Employer Resources (10)
FDA (443)
Job Trends (782)
News (20272)
Policy (1057)
Tag
Academia (144)
Allergies (7)
Alliances (3491)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (31)
Autoimmune disease (9)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (327)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (33)
CDC (1)
Cell therapy (84)
Cervical cancer (2)
Clinical research (3442)
Collaboration (202)
Company closure (2)
Compensation (105)
COVID-19 (185)
CRISPR (11)
C-suite (114)
Cystic fibrosis (7)
Data (424)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (492)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (44)
Earnings (4516)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6415)
Executive appointments (135)
FDA (590)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (57)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (708)
HIV (2)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (5)
Infectious disease (198)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (26)
Interviews (7)
IPO (1002)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (315)
Medtech (316)
Mergers & acquisitions (1224)
Metabolic disorders (72)
Multiple sclerosis (23)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (167)
NextGen: Class of 2026 (353)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (18)
Pain (25)
Pancreatic cancer (22)
Parkinson's disease (12)
Partnered (4)
Patents (53)
Patient recruitment (28)
Peanut (1)
People (5879)
Pharmaceutical (5)
Phase 1 (1477)
Phase 2 (1704)
Phase 3 (916)
Pipeline (408)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (15)
Rare diseases (63)
Real estate (425)
Recruiting (5)
Regulatory (920)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (1)
Last 7 days (53)
Last 30 days (153)
Last 365 days (2435)
2026 (265)
2025 (2438)
2024 (2610)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1948)
Australia (307)
California (1616)
Canada (249)
China (81)
Colorado (55)
Connecticut (16)
Delaware (5)
Europe (4021)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (3)
Indiana (61)
Japan (18)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (576)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (137)
New York (81)
North Carolina (133)
Northern California (790)
Ohio (45)
Oklahoma (2)
Oregon (6)
Pennsylvania (113)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (1)
Southern California (658)
Tennessee (5)
Texas (153)
United States (3242)
Utah (5)
Virginia (12)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,142 Results for "andelyn biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Andelyn Biosciences Announces Partnership with Jaguar Gene Therapy to Provide Late-Stage PPQ Manufacturing
December 8, 2025
·
5 min read
Press Releases
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
November 18, 2025
·
8 min read
Press Releases
Andelyn Biosciences and Amplo Biotechnology Partner to Manufacture Novel Gene Therapies for Diseases Affecting the Neuromuscular Junction
August 22, 2025
·
3 min read
Press Releases
Andelyn Biosciences and Tern Therapeutics Partner for Late-Stage Process Performance Qualification (PPQ) Manufacturing of AAV Gene Therapy for the Treatment of CLN2 Batten Disease
September 4, 2025
·
3 min read
Press Releases
Andelyn Biosciences Applies the AAV Curator® Platform to Deliver Novel Gene Therapy for an Ultra-Rare NEDAMSS Disease Patient 14-Months after Diagnosis
May 12, 2025
·
5 min read
Press Releases
Andelyn Biosciences AAV Curator® Platform Used to Manufacture Clinical Grade Viral Vector for FDA-Authorized First-In-World Universal Donor CRISPR/AAV Transduced CAR-NK Cells
May 7, 2025
·
3 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the California Institute for Regenerative Medicine (CIRM) Accelerating Medicines Partnership (AMP) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies using its suspension AAV Curator™ Platform under the California Institute for Regenerative Medicine Accelerating Medicines Partnership Bespoke Gene Therapy Consortium.
May 23, 2024
·
3 min read
Press Releases
Andelyn Biosciences Expands AAV Curator™ Platform Offering to Include Stanton Lab CNS Capsids through a License Agreement from the Broad Institute of MIT and Harvard
February 19, 2025
·
3 min read
BioMidwest
Andelyn Biosciences Selected as Viral Vector Manufacturing Partner for the Foundation for the National Institutes of Health (FNIH) Accelerating Medicines Partnership® (AMP®) Bespoke Gene Therapy Consortium (BGTC)
Andelyn Biosciences, Inc. has been selected to manufacture adeno-associated vectors therapies in its suspension platform for several programs under the Foundation for the National Institutes of Health Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium.
February 28, 2024
·
3 min read
Business
Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies
Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization, is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies.
November 9, 2023
·
3 min read
1 of 4,015
Next
